The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...

A host of Cambridgeshire people - from charity leaders to academics - have been honoured in His Majesty The King’s Birthday ...

The guidelines include disease-specific recommendations screening, monitoring disease progression, and treatment options for ILD.